HighVista Strategies »

Inhibrx Biosciences shares owned by HighVista Strategies

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $257k 7.6k 33.68

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Woodline Partners
Millennium Management
Partner Fund Management
Caligan Partners
Geode Capital Management
State Street Corporation
Readystate Asset Management
Kennedy Capital Management

View all funds holding Inhibrx Biosciences